News Archives - Page 78 of 87

ThursdayAug 11, 2022 12:14 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Discusses Biotech Industry Valuation Metrics

Lexaria Bioscience (NASDAQ: LEXX, LEXXW) is a global innovator in drug delivery platforms. The company today issued information to its stakeholders as an aid to conveniently research and understand various non-affiliated third-party sources and their methodologies for valuing biotech and pharmaceutical companies. “Biotech companies with little to no revenue can still be worth billions,” Raphael Rottgen, CFA, FRM, was quoted in the press release. “While valuations can be extremely low or extremely high, there is often underlying logic in identifying risks and arriving at those valuations. Developing new drugs can have significant costs of over $1 billion and can take…

ThursdayAug 11, 2022 10:28 am

TinyGemsBreaks – GreenBox POS (NASDAQ: GBOX) Announces Participation in Upcoming Q3 Investor Summit

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, will be presenting at the upcoming Q3 Investor Summit. The two-day event, which is slated for Aug. 16–17, 2022, is hosted by Investor Summit Group. GreenBox chair Ben Errez will be presenting virtually; his presentation is scheduled for Aug. 17, 2022, at 12:30 p.m. ET. In addition, Errez will host one-on-one meetings with investors during the summit. The Q3 Investor Summit is designed to connect companies with leading investors. To view the webcast, visit https://ibn.fm/ZR6NV To view the full press release, visit https://ibn.fm/nQfoR About GreenBox POS GreenBox is an emerging financial technology…

WednesdayAug 10, 2022 12:35 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Positive FDA Feedback Concerning Opening IND Program

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its receipt of a positive full written response from the Food and Drug Administration (“FDA”) from its pre-Investigational New Drug (“Pre-IND”) meeting regarding DehydraTECH-CBD for the treatment of hypertension. According to the update, the FDA confirmed agreement with Lexaria’s proposal to pursue a 505(b)(2) new drug application (“NDA”) regulatory pathway for its program. This is advantageous because the abbreviated pathway, as it is often described, typically enables a faster route to commercial approval than the traditional 505(b)(1) NDA pathway. “We are very pleased to have received…

WednesdayAug 10, 2022 12:16 pm

TinyGemsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Earnings Conference Call, Webcast

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, has scheduled a conference call and webcast to discuss its earnings for the first half of 2022. The call is slated for Monday, Aug. 15, 2022, at 4:30 p.m. ET. the company plans to release its financial report and numbers prior to the call. During the call, company officials will discuss the financial and operations results as well as provide an update on the company’s operations, house of brands and life sciences strategies; the event will also include time for a Q&A. An…

TuesdayAug 09, 2022 1:11 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Preliminary Q3 Results

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced preliminary third-quarter results. According to the update, in addition to recent highlights and successes for the company and its EV programs, Mullen is in a strong financial position, with approximately $99 million in cash and cash equivalents on hand as of Aug. 8, 2022. Among the highlights, the company reported asset growth of 391% and positive working capital of $27,656,446. “It’s an exciting and pivotal time for Mullen as we continue to experience exceptional growth,” said David Michery, CEO and chairman of Mullen Automotive. “We’ve been focused on…

TuesdayAug 09, 2022 12:37 pm

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Board Appointment, Changes

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced the appointment of Nicole Lemerond to its board of directors, effective immediately. Lemerond is a financial executive with over 25 years of experience in investment management, private equity, investment banking and leveraged finance. Throughout her career, she has established and led health care groups at leading investment firms and has also worked at several large financial institutions, including Lehman Brothers and The Carlyle Group. Concurrent with Lemerond’s appointment, Adam Cutler has decided to transition off the board of directors. Cutler has served…

TuesdayAug 09, 2022 11:53 am

TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Unveils Equity Program, Releases Q1 Financial Report

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has announced an at-the-market equity program allowing the company to issue and sell up to $35 million of common shares. According to the announcement, the shares can be sold “from time to time” through the Neo Exchange, the NYSE American LLC or any other “marketplace” upon which the shares are listed, quoted or traded, at the prevailing market price at the time of sale. The company anticipates using any proceeds from the sales of these shares for growth opportunities and working capital initiatives. In addition, Cybin…

TuesdayAug 09, 2022 10:12 am

TinyGemsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Releases Q2 2022 Financial Report, Corporate Update

Cepton Technologies (NASDAQ: CPTN) is reporting its financial results for the second quarter 2022, the period ended June 30, 2022; the report also included business updates for the Silicon Valley innovator and leader in high-performance Micro Motion Technology(RM) (“MMT”) lidar solutions. Highlights of the report included news of CPTN’s OEM Series production execution, including continued ramp of D-sample shipments for end delivery to multiple OEM vehicle manufacturing plants across multiple states as well as the completion of a lead-OEM site audit of the company’s Japan manufacturing facility; in addition, the report noted that Cepton has selected Fabrinet as key submodule supplier…

MondayAug 08, 2022 12:22 pm

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Names New Design VP

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has appointed Andre Hudson as its new vice president of design. An experienced vehicle design expert, Hudson has a track record of compelling design and brand vision leadership, including several highly successful concept and production vehicles in the marketplace. During his 25-year career, he has served a head of product design at IndiEV in addition to working with General Motors Co., Hyundai and Icona Design. “We are fortunate to have Andre on board,” said Mullen Automotive CEI and chair David Michery in the press release. “He will play a key…

MondayAug 08, 2022 11:24 am

TinyGemsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Reports Second Quarter 2022 Results

Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading uranium producer in the United States, has filed its Q2 2022 financial results for the period ended June 30, 2022; the company also scheduled a webcast to discuss those results. The webcast is slated for Aug. 9, 2022, at 4 p.m. EDT. Highlights of the report show that Energy Fuels has a robust balance sheet with $134.1 million of working capital; total includes $86.4 million in cash and cash equivalents, $11.8 million marketable securities and $28.6 million of inventory with no debt; the report noted that at current commodity prices, the company's product inventory has a…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Breaks Categories: News